Terry Litchfield, MPA, CPC

ESRD Patient Advocate

Connect With Terry

Terry Litchfield, MPA, CPC, brings over 30 years of dedicated experience in the healthcare field, with a specialized focus on dialysis-related care. Navigating the ever-evolving healthcare landscape, Terry possesses a unique insight into the changes impacting endovascular disease treatments, particularly in the realm of renal patients.

Twenty-four years ago, Terry co-founded Lifeline Vascular Access, emerging as an early leader in dialysis access care beyond hospital settings. Renowned for her expertise in technology assessment and outcomes research for vascular access and chronic kidney disease patients, Terry has authored multiple publications in the field. Her influence extends nationally, marked by frequent presentations on dialysis vascular access, new technology reimbursement and regulatory pathways, as well as patient engagement and satisfaction with care.

A passionate patient advocate, Terry’s personal connection to renal replacement therapy is profound, as her late husband, Bill, celebrated 46 years of such therapy before his passing. Terry has actively served on impactful organizations such as the KHI Patient and Family Partnership Council and AAKP, demonstrating her commitment to patient advocacy. She plays a key role in the Dialysis Vascular Access Coalition and the American Society of Diagnostic and Interventional Nephrology, where she received the Lifeline Achievement Award in 2018.

In addition to her advocacy, Terry serves as a consultant to several startup med tech groups in the vascular field. Whether as a care partner during home dialysis or in support of in-center care, Terry intimately understands the impact of kidney disease on families. Her background in Hospital Administration at renowned tertiary institutions in the US provides a unique perspective on health services and program planning. Terry has been actively engaged in regulatory activities at CMS and FDA, focusing on new devices and innovative programs at CMMI. Explore more about Terry’s wealth of experience and commitment to advancing dialysis access solutions at dialysisaccesssolutions.com.

Terry Litchfield, MPA, CPC, brings over 30 years of dedicated experience in the healthcare field, with a specialized focus on dialysis-related care. Navigating the ever-evolving healthcare landscape, Terry possesses a unique insight into the changes impacting endovascular disease treatments, particularly in the realm of renal patients.

Twenty-four years ago, Terry co-founded Lifeline Vascular Access, emerging as an early leader in dialysis access care beyond hospital settings. Renowned for her expertise in technology assessment and outcomes research for vascular access and chronic kidney disease patients, Terry has authored multiple publications in the field. Her influence extends nationally, marked by frequent presentations on dialysis vascular access, new technology reimbursement and regulatory pathways, as well as patient engagement and satisfaction with care.

A passionate patient advocate, Terry’s personal connection to renal replacement therapy is profound, as her late husband, Bill, celebrated 46 years of such therapy before his passing. Terry has actively served on impactful organizations such as the KHI Patient and Family Partnership Council and AAKP, demonstrating her commitment to patient advocacy. She plays a key role in the Dialysis Vascular Access Coalition and the American Society of Diagnostic and Interventional Nephrology, where she received the Lifeline Achievement Award in 2018.

In addition to her advocacy, Terry serves as a consultant to several startup med tech groups in the vascular field. Whether as a care partner during home dialysis or in support of in-center care, Terry intimately understands the impact of kidney disease on families. Her background in Hospital Administration at renowned tertiary institutions in the US provides a unique perspective on health services and program planning. Terry has been actively engaged in regulatory activities at CMS and FDA, focusing on new devices and innovative programs at CMMI. Explore more about Terry’s wealth of experience and commitment to advancing dialysis access solutions at dialysisaccesssolutions.com.